XML 66 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Number of Restricted Shares      
Granted (in shares) 500,000 400,000  
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 6.52 $ 3.10  
Restricted Stock      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 341,211    
Vested (in shares) (133,515)    
Forfeited (in shares) (25,620)    
Unvested, end of period (in shares) 658,330   341,211
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 4.54    
Vested (in USD per share) 5.37    
Forfeited (in USD per share) 6.51    
Unvested, end of period (in USD per share) $ 6.24   $ 4.54
Unamortized compensation expense $ 3,279   $ 1,092
Weighted Average Remaining Amortization Period (Years) 2 years 6 months   2 years 1 month 6 days
Restricted Stock, Performance Based      
Number of Restricted Shares      
Granted (in shares) 100,239 100,000  
Unvested, end of period (in shares) 192,789    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.39    
Unvested, end of period (in USD per share) $ 5.30    
Restricted Stock Time Vested      
Number of Restricted Shares      
Granted (in shares) 376,015 200,000  
Unvested, end of period (in shares) 465,541    
Weighted Average Grant-Date Fair Value      
Granted (in USD per share) $ 7.18    
Unvested, end of period (in USD per share) $ 6.63    
Contingent Restricted Stock Grants      
Number of Restricted Shares      
Unvested, beginning of period (in shares) 50,062    
Granted (in shares) 50,123    
Forfeited (in shares) (3,787)    
Unvested, end of period (in shares) 96,398   50,062
Weighted Average Grant-Date Fair Value      
Unvested, beginning of period (in USD per share) $ 2.21    
Granted (in USD per share) 4.79    
Forfeited (in USD per share) 3.69    
Unvested, end of period (in USD per share) $ 3.49   $ 2.21
Unamortized compensation expense $ 227   $ 68
Weighted Average Remaining Amortization Period (Years) 2 years 1 month 6 days   1 year 8 months 12 days